Enhanced short-term improvement of insulin response to a low-caloric diet in obese carriers the Gly482Ser variant of the PGC-1α gene

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 190-196

  Goyenechea, Estibaliz ^a   Crujeiras, Ana B ^a   Abete, Itziar ^a   Parra, Dolores ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Insulin resistance; Obesity; PGC 1 ; Polymorphism; Type 2 diabetes; Weight regulation; Weight loss

Indexed keywords

GLYCINE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SERINE;

ADULT; ARTICLE; BODY MASS; DIET THERAPY; FEMALE; FOLLOW UP; GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; OBESITY; PGC 1ALPHA GENE; PHENOTYPE; PROGNOSIS; SPAIN; WEIGHT REDUCTION;

ADULT; DIET, CARBOHYDRATE-RESTRICTED; FEMALE; GENOTYPE; HEAT-SHOCK PROTEINS; HUMANS; INSULIN RESISTANCE; MALE; MUTATION, MISSENSE; OBESITY; TRANSCRIPTION FACTORS; WEIGHT LOSS;

EID: 54549090862     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.011     Document Type: Article

References (45)

1. Moller D.E., and Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56 (2005) 45-62
2. Kahn C.R., Vicent D., and Doria A. Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu. Rev. Med. 47 (1996) 509-531
3. Lehtovirta M., Kaprio J., Forsblom C., Eriksson J., Tuomilehto J., and Groop L. Insulin sensitivity and insulin secretion in monozygotic and dizygotic twins. Diabetologia 43 (2000) 285-293
4. Rai E., Sharma S., Koul A., Bhat A.K., Bhanwer A.J., and Bamezai R.N. Interaction between the UCP2-866G/A, mtDNA 10398G/A and PGC1alpha p.Thr394Thr and p. Gly482Ser polymorphisms in type 2 diabetes susceptibility in North Indian population. Hum. Genet. 122 (2007) 535-540
5. Uusitupa M. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study. Nutr. Metab. Cardiovasc. Dis. 15 (2005) 225-233
6. Horiki M., Ikegami H., Fujisawa T., Kawabata Y., Ono M., Nishino M., et al. Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases. Diabetes Res. Clin. Pract. 66 Suppl. 1 (2004) S63-S67
7. Yoon J.C., Puigserver P., Chen G., Donovan J., Wu Z., Rhee J., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 (2001) 131-138
8. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003) 78-90
9. Pratley R.E., Thompson D.B., Prochazka M., Baier L., Mott D., Ravussin E., et al. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J. Clin. Invest. 101 (1998) 1757-1764
10. Arya R., Duggirala R., Jenkinson C.P., Almasy L., Blangero J., O'Connell P., et al. Evidence of a novel quantitative-trait locus for obesity on chromosome 4p in Mexican Americans. Am. J. Hum. Genet. 74 (2004) 272-282
11. Bhat A., Koul A., Rai E., Sharma S., Dhar M.K., and Bamezai R.N. PGC-1alpha Thr394Thr and Gly482Ser variants are significantly associated with T2DM in two North Indian populations: a replicate case-control study. Hum. Genet. 121 (2007) 609-614
12. Barroso I., Luan J., Sandhu M.S., Franks P.W., Crowley V., Schafer A.J., et al. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49 (2006) 501-505
13. Ek J., Andersen G., Urhammer S.A., Gaede P.H., Drivsholm T., Borch-Johnsen K., et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44 (2001) 2220-2226
14. Hara K., Tobe K., Okada T., Kadowaki H., Akanuma Y., Ito C., et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to type II diabetes. Diabetologia 45 (2002) 740-743
15. Muller Y.L., Bogardus C., Pedersen O., and Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 52 (2003) 895-898
16. Esterbauer H., Oberkofler H., Linnemayr V., Iglseder B., Hedegger M., Wolfsgruber P., et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes 51 (2002) 1281-1286
17. Ambye L., Rasmussen S., Fenger M., Jørgensen T., Borch-Johnsen K., Madsbad S., et al. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res. Clin. Pract. 67 (2005) 175-179
18. Abete I., Parra M., and Martinez J. Different dietary strategies for weight loss in obesity: role of energy and macronutrient content. Nutr. Res. Rev. 19 (2006) 1-14
19. Aberle J., Evans D., Beil F.U., and Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin. Genet. 68 (2005) 152-154
20. Goyenechea E., Parra D., and Martinez J.A. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br. J. Nutr. 96 (2006) 965-972
21. Levine J.A., Eberhardt N.L., and Jensen M.D. Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283 (1999) 212-214
22. Stefan N., Thamer C., Staiger H., Machicao F., Machann J., Schick F., et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J. Clin. Endocrinol. Metab. 92 (2007) 1827-1833
23. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, Circulation 106, 2002, pp. 3143-3421.
24. Crujeiras A.B., Parra M.D., Rodriguez M.C., Martínez de Morentin B.E., and Martínez J.A. A role for fruit content in energy-restricted diets in improving antioxidant status in obese women during weight loss. Nutrition 22 (2006) 593-599
25. Goyenechea E., Parra D., and Martinez J.A. Impact of interleukin 6-174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight. Metabolism 56 (2007) 1643-1648
26. Abete I., Parra D., and Martinez J.A. Energy-restricted diets based on a distinct food selection affecting the glycemic index induce different weight loss and oxidative response. Clin. Nutr. (2008) [Epub ahead of print]
27. Martinez-Gonzalez M.A., Lopez-Fontana C., Varo J.J., Sánchez-Villegas A., and Martinez J.A. Validation of the Spanish version of the physical activity questionnaire used in the Nurses' Health Study and the Health Professionals' Follow-up Study. Public Health Nutr. 8 (2005) 920-927
28. Perez S., Parra M., Martínez de Morentin B., Rodríguez M.C., and Martínez J.A. Evaluation of the intraindividual variability of the measurement of body composition by means of bioimpendance in healthy volunteers and its relation with body mass index and triceps skinfolds. Enferm. Clin. 15 (2005) 307-314
29. Salas-Salvadó J., et al. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria. Med. Clin. 5 (2007) 184-196
30. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18 (1972) 499-502
31. Parra M.D., Martinez de Morentin B.E., and Martinez J.A. Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight. Eur. J. Clin. Nutr. 59 (2005) 334-340
32. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 26, 2003, pp. S5-S20.
33. Kunej T., Globocnik Petrovic M., Dovc P., Peterlin B., and Petrovic D. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians. Folia Biol. 50 (2004) 157-158
34. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413 (2001) 179-183
35. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., et al. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10 (2004) 530-534
36. Fanelli M., Filippi E., Sentinelli F., Romeo S., Fallarino M., Buzzetti R., et al. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects. Dis. Markers 21 (2005) 175-180
37. Andrulionyte L., Zacharova J., Chiasson J.L., and Laakso M. Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47 (2004) 2176-2184
38. Lacquemant C., Chikri M., Boutin P., Samson C., and Froguel P. No association between the G482S polymorphism of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene and type II diabetes in French Caucasians. Diabetologia 45 (2002) 602-603 [author reply 604]
39. Stumvoll M., Fritsche A., t'Hart L.M., Machann J., Thamer C., Tschritter O., et al. The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations. Exp. Clin. Endocrinol. Diabetes 112 (2004) 253-257
40. Marti A., Martinez-Gonzalez M.A., and Martinez J.A. Interaction between genes and lifestyle factors on obesity. Proc. Nutr. Soc. 67 (2008) 1-8
41. Douketis J.D., and Sharma A.M. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction. Semin. Vasc. Med. 5 (2005) 25-33
42. Morris A.M., Heilbronn L.K., Noakes M., Kind K.L., and Clifton P.M. -308 Nco I polymorphism of tumour necrosis factor alpha in overweight Caucasians. Diabetes Res. Clin. Pract. 62 (2003) 197-201
43. Halverstadt A., Phares D.A., Roth S., Ferrell R.E., Goldberg A.P., and Hagberg J.M. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim. Biophys. Acta 1734 (2005) 143-151
44. Shin M.J., Jang Y., Koh S.J., Chae J.S., Kim O.Y., Lee J.E., et al. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int. J. Obes. (London) 30 (2006) 1702-1708
45. Lachin J.M. A review of methods for futility stopping based on conditional power. Stat. Med. 24 (2005) 2747-2764